Skip to main content
. 2022 Jun 22;31(9):1849–1857. doi: 10.1158/1055-9965.EPI-22-0114

Table 2.

Logistic regression estimate of oral cancer incidence among Medicaid and commercial enrollees.

Medicaid Commercial
Effect N OR (95% Wald confidence limits) P N OR (95% Wald confidence limits) P
Age group (ref = 21–30) 64 <0.0001 36 <0.0001
 31–40 125 1.84 (1.36–2.48) 75 2.10 (1.41–3.13)
 41–50 278 5.22 (3.97–6.85) 186 4.56 (3.19–6.52)
 51–60 875 13.37 (10.36–17.27) 569 11.82 (8.44–16.56)
 61–64 403 17.10 (13.12–22.29) 368 17.34 (12.31–24.43)
Sex (ref = male) 1,118 <0.0001 810 <0.0001
 Female 627 0.46 (0.41–0.50) 424 0.46 (0.41–0.52)
Race and ethnicity (ref = white)a 1,062 <0.0001
 Black 375 0.66 (0.59–0.74)
 Hispanic 25 0.78 (0.52–1.15)
 Other 29 0.84 (0.58–1.21)
Elixhauser Comorbidities
 Tobacco 1,040 2.84 (2.57–3.13) <0.0001 140 2.21 (1.85–2.65) <0.0001
 Alcohol 337 2.24 (1.98–2.54) <0.0001 48 2.73 (2.03–3.67) <0.0001
 HIV/AIDS 40 1.89 (1.38–2.60) <0.0001 7 2.26 (1.07–4.76) 0.0302
Dental Prior Year (ref = no) 1,472 <0.0001 410 <0.0001
 Yes 273 0.71 (0.62–0.80) 824 0.41 (0.36–0.46)

aData on race or ethnicity not available in the commercial insurance dataset. White, Black, and Other were all non-Hispanic.